Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Why Moderna Has More Upside Than Its Covid-19 Vaccine Implies

By Chris Lau, InvestorPlace Contributor

The wild volatility in Moderna stock before and after its vaccine approval is coming to an end but its long-term prospects are on the way up.

Luckin Stock May Be a Long-Shot Worth Betting On

By Chris Lau, InvestorPlace Contributor

Formerly thought of as the Starbucks of China, Luckin stock is on the mend as the company settles with the SEC and grows its business.

9 Stocks That Investors Think Are the Next Amazon

By Chris Lau, InvestorPlace Contributor

There's more than AMZN stock when it comes to e-commerce and beyond. As the moats of these nine stocks to buy widen, the upsides increase.

Nio Stock Could Jump to Nearly $100 Per Share

By Chris Lau, InvestorPlace Contributor

Positive catalysts lifted Nio stock to all-time highs as investors rush to buy anything EV-related, Nio is poised to climb further.

Even After This Massive Run, AMD Stock Is Still a Solid Buy

By Chris Lau, InvestorPlace Contributor

AMD’s strong growth ahead will continue in 2021 as Intel stumbles in the PC and server markets and gives away its market share.

Load More